Genetic Technologies Limi...

NASDAQ: GENE · Real-Time Price · USD
0.77
0.01 (0.65%)
At close: Nov 14, 2024, 10:00 PM

Revenue by Geography

Period Ending Jun 30, 2022
Asia Pacifics Revenue n/a
Asia Pacifics Revenue Growth n/a
Europe Middleeast And Africa Revenue n/a
Europe Middleeast And Africa Revenue Growth n/a

Operating Expense Breakdown

Period Ending Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Jun 30, 2020 Dec 31, 2019 Jun 30, 2019 Dec 31, 2018 Jun 30, 2018 Dec 31, 2017 Jun 30, 2017 Dec 31, 2016 Jun 30, 2016 Dec 31, 2015 Jun 30, 2015
Selling, General, and Administrative Revenue 5.9M 3.71M 3.65M 4.11M 8.66M 2.85M 3.58M 2.3M 1.77M 1.29M 3.11M 2.57M 2.01M 2.16M 2.15M 1.82M 2.27M 2.63M 3.03M 3M 3.19M 4.13M
Selling, General, and Administrative Revenue Growth +59.24% +1.57% -11.22% -52.56% +203.87% -20.41% +55.53% +30.41% +36.87% -58.54% +20.93% +27.95% -6.69% +0.25% +18.46% -19.88% -13.77% -13.16% +1.05% -6.20% -22.77% n/a
Research and Development Revenue 363K 389.76K 722.85K 558.31K -1.43M 167.27K 2.13M 185.48K 2.05M 51.92K 1.06M 1.35M 1.13M 959.57K 1.4M 1.15M 1.06M 1.23M 1.13M 1.53M 1.16M 1.13M
Research and Development Revenue Growth -6.87% -46.08% +29.47% -139.17% -952.18% -92.15% +1048.89% -90.94% +3843.94% -95.11% -21.32% +19.62% +17.57% -31.52% +21.36% +9.34% -14.49% +9.15% -25.93% +31.59% +3.01% n/a
Sales and Marketing Revenue 1.57M 1.25M 1.3M 1.65M 1.14M 570.2K 901.63K 450.82K 162.31K 81.16K 598.59K 360.75K 276.55K 346.93K 229.14K 21.85K 762.06K 1.33M 1.39M 1.49M 1.69M 1.68M
Sales and Marketing Revenue Growth +25.36% -3.34% -21.44% +44.79% +100.00% -36.76% +100.00% +177.75% +100.00% -86.44% +65.93% +30.44% -20.29% +51.40% +948.67% -97.13% -42.65% -4.60% -6.74% -11.79% +0.77% n/a